Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: A study of their frequency, associated diagnostic problems, and prognostic significance

International Journal of Gynecological Pathology

Volumn 22, Issue 4, 2003, Pages 324-333

  Murray, Shawn K ^a,b   Young, Robert H ^c   Scully, Robert E ^c  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Carcinoma; Endometrioid carcinoma; Endometrium; Fibromyxoid stroma; Lymphocytic reaction; Prognosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD VESSEL; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CELL DIFFERENTIATION; CELL INVASION; CELL TYPE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; EPITHELIUM CELL; FEMALE; FIBROMYXOID CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPHATIC SYSTEM; LYMPHOCYTE; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MIXED LYMPHOCYTE REACTION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUSCLE CELL; MYOMETRIUM; OUTCOMES RESEARCH; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; STROMA CELL; SURVIVAL; TUMOR NECROSIS;

EID: 0141680994     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000092161.33490.a9     Document Type: Article

References (29)

1. Baram A, Figer A, Inbar M, et al. Endometrial carcinoma stage I-comparison of two different treatment regimes-evaluation of risk factors and its influence on prognosis; suggested step-by-step treatment protocol. Gynecol Oncol 1985;22:294-301.
2. Burrell MO, Franklin EW 3rd, Powell JL. Endometrial cancer: evaluation of spread and follow-up one hundred eighty-nine patients with Stage I or Stage II disease. Am J Obstet Gynecol 1982; 144:181-5.
3. Christopherson WM, Connelly PJ, Alberhasky RC. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease. Cancer 1983;51: 1705-9.
4. Genest P, Drouin P, Gerig L, et al. Prognostic factors in early carcinoma of the endometrium. Am J Clin Oncol 1987;10:71-7.
5. Lee KR, Vacek PM, Belinson JL. Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol Oncol 1994;54:10-8.
6. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
7. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 1987;60:2035-41.
8. Hanson MB, van Nagell JR Jr, Powell DE, et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 1985;55:1753-7.
9. Mariani A, Webb MJ, Keeney GL, et al. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol 2002;86: 38-44.
10. Ayhan A, Tuncer ZS, Tuncer R, et al. Risk factors for recurrence in clinically early endometrial carcinoma: an analysis of 183 consecutive cases. Eur J Obstet Gynecol Reprod Biol 1994;57:167-70.
11. Ambros RA, Kurman RJ. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992; 69:1424-31.
12. Lotocki RJ, Copeland LJ, DePetrillo AD, et al. Stage I endometrial adenocarcinoma: treatment results in 835 patients. Am J Obstet Gynecol 1983;146:141-5.
13. Ambros RA, Kurman RJ. Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecol Oncol 1992;45:235-9.
14. Alektiar KM, McKee A, Lin O, et al. The significance of the amount of myometrial invasion in patients with stage IB endometrial carcinoma. Cancer 2002;95:316-21.
15. Mariani A, Webb MJ, Keeney GL, et al. Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol 2002;87:274-80.
16. Mariani A, Webb MJ, Keeney GL, et al. Hematogenous dissemination in corpus cancer. Gynecol Oncol 2001;80:233-8.
17. Zaino RJ, Kurman R, Herbold D, et al. The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study. Cancer 1991;68:2293-302.
18. Inoue Y, Obata K, Abe K, et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 1996;78: 1447-51.
19. Mariani A, Webb MJ, Keeney GL, et al. Endometrial cancer: predictors of peritoneal failure. Gynecol Oncol 2003;89:236-42.
20. Mariani A, Webb MJ, Keeney GL, et al. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 2002;84:437-42.
21. Larson DM, Copeland LJ, Gallager HS, et al. Prognostic factors in stage II endometrial carcinoma. Cancer 1987;60:1358-61.
22. Ayhan A, Taskiran C, Yuce K, et al. The prognostic value of nuclear grading and the revised FIGO grading of endometrial adenocarcinoma. Int J Gynecol Pathol 2003;22:71-4.
23. Mittal KR, Barwick KW. Diffusely infiltrating adenocarcinoma of the endometrium. A subtype with poor prognosis. Am J Surg Pathol 1988;12:754-8.
24. Longacre TA, Hendrickson MR. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. Am J Surg Pathol 1999;23:69-78.
25. Yamazawa K, Seki K, Matsui H, et al. Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. Cancer 2001;91: 1777-84.
26. Spiegel GW. Free mucin in the myometrium associated with endometrial adenocarcinoma. Mod Pathol 1992;5:68A.
27. Ambros RA, Malfetano JH, Mihm MC Jr. Clinicopathologic features of vulvar squamous cell carcinomas exhibiting prominent fibromyxoid stromal response. Int J Gynecol Pathol 1996;15: 137-45.
28. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2002;9:145-84.
29. Marshall DS, Hummer A, Thaler H, et al. Myometrial invasion patterns are associated with lymphovascular invasion in endometrioid adenocarcinoma of the endometrium. Mod Pathol 2003;16: 200A.